Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atypical Antipsychotic Medication in Anorexia Nervosa
NCT00692185Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Oct 2005
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in anorexia nervosa (AN), sponsored by New York State Psychiatric Institute. Started Oct 2005; status: completed.
02
Drugs
olanzapine
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT00692185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00692185.